Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CADL
Stock Latest News
Ratings
Positive Buy Rating for Candel Therapeutics Driven by Promising Phase 3 Results of CAN-2409 and Strong Regulatory Prospects
4m ago
CADL
Premium
The Fly
Candel Therapeutics initiated with an Outperform at LifeSci Capital
9m ago
CADL
Premium
The Fly
Candel Therapeutics appoints Pulendran to Candel’s RAB
5d ago
CADL
Premium
Ratings
Candel Therapeutics: Hold Rating Amid Promising Developments and Financial Uncertainty
6d ago
CADL
Premium
Company Announcements
Candel Therapeutics Secures $130M Loan for Trials
7d ago
8K
CADL
Premium
The Fly
Candel Therapeutics enters into $130M term loan facility
7d ago
CADL
TRIN
Premium
The Fly
Candel Therapeutics announces interim data from phase 1b CAN-3110 trial
7d ago
CADL
Premium
The Fly
Trinity Capital provides $130M in growth capital to Candel Therapeutics
7d ago
CADL
TRIN
Premium
Ratings
Promising Investment: Candel Therapeutics’ CAN-2409 Shows Efficacy in Prostate Cancer with Potential for Broader Applications
14d ago
CADL
Premium
Ratings
Promising Potential of Candel Therapeutics’ CAN-2409: A Versatile Immunotherapy with Broad Applicability
22d ago
CADL
Premium
The Fly
Candel Therapeutics presents Phase 3 clinical trial of CAN-2409
22d ago
CADL
Premium
The Fly
Candel Therapeutics downgraded to Neutral at BofA on lack of catalysts
2M ago
CADL
Premium
The Fly
Candel Therapeutics downgraded to Neutral from Buy at BofA
2M ago
CADL
Premium
The Fly
Candel Therapeutics appoints Carl June to Research Advisory Board
2M ago
CADL
Premium
Company Announcements
Candel Therapeutics Extends Lease Agreement in Needham
2M ago
8K
CADL
Premium
Company Announcements
Candel Therapeutics Advances with Promising Cancer Therapies
2M ago
CADL
Premium
Company Announcements
Candel Therapeutics Faces Uncertainty Despite FDA RMAT Designation for Prostate Cancer Treatment
2M ago
CADL
Premium
Ratings
Candel Therapeutics’ CAN-2409: Promising Phase 3 Results and Market Potential
2M ago
CADL
Premium
Ratings
Candel Therapeutics: Promising Pipeline Developments and Strategic Advancements Support Buy Rating
2M ago
CADL
Premium
The Fly
Candel Therapeutics files $300M mixed securities shelf
2M ago
CADL
Premium
The Fly
Candel Therapeutics reports Q2 EPS (9c) vs. (74c) last year
2M ago
CADL
Premium
The Fly
Candel Therapeutics sees cash runway into 1Q27
2M ago
CADL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
